Carregant...

Advances in Prognostic Methylation Biomarkers for Prostate Cancer

There is a major clinical need for accurate biomarkers for prostate cancer prognosis, to better inform treatment strategies and disease monitoring. Current clinically recognised prognostic factors, including prostate-specific antigen (PSA) levels, lack sensitivity and specificity in distinguishing a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Dilys Lam, Susan Clark, Clare Stirzaker, Ruth Pidsley
Format: Artigo
Idioma:Inglês
Publicat: MDPI AG 2020-10-01
Col·lecció:Cancers
Matèries:
Accés en línia:https://www.mdpi.com/2072-6694/12/10/2993
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!